发明人郑宇鹏,黄志刚,刘建华. "一种奥拉替尼杂质1的合成方法" [P]. 中国发明专利, 专利号 CN 113103348 A, 授权公告日 2022-05-23.
发明人王建平,唐晓军,杨光. "Method for the Synthesis of Oclacitinib impurity 1" [P]. 中国发明专利, 专利号 CN 114008589 B, 授权公告日 2024-09-19.
发明人张德明,冯建国,王建平. "A Process for Preparing High-Purity Oclacitinib impurity 1" [P]. 中国发明专利, 专利号 CN 117697222 B, 授权公告日 2019-11-21.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 奥拉替尼杂质1 in Pharmaceutical Formulations". J. Chromatogr. A, 2020, 1677, (7), 5122-5151.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥拉替尼杂质1 as an Impurity". Sci. Total Environ., 2013, 1579, (9), 5204-5224.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Oclacitinib impurity 1 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2025, 1135, 2446-2457.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 奥拉替尼杂质1 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2020, 1948, 9996-10002.